Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Glucose and Telmisartan

supplement:

Glucose

Research Papers that Mention the Interaction

In an animal model of insulin resistance, telmisartan lowered serum levels of glucose , insulin and triglycerides, and body weight.
Expert opinion on pharmacotherapy  •  2004  |  View Paper
…,telmisartan … glucose and insulin at 0.5 h since OGTT (7.64 ± 1.86 mmol/l·min vs 6.77 ± 0.83 mmol/l·min, P = … 60.20 ± 24.20 μIU/ml·min, P = 0.037), though the AUC of glucose and insulin after OGTT showed no significant difference.
Journal of pharmacological sciences  •  2019  |  View Paper
Animal experiments have confirmed that telmisartan can regulate glucose and lipid metabolism, and improve IR.
American journal of therapeutics  •  2018  |  View Paper
Compared to placebo, telmisartan resulted in a reduction in homeostasis model assessment index (-11%, P = .06) and glucose area under the curve during intravenous glucose tolerance (-11%, P = .04).
Metabolism: clinical and experimental  •  2006  |  View Paper
While the beneficial effect of Telmisartan on glucose and lipid metabolism has been reported, the underlying molecular mechanism remained unclear.
Biochemical and biophysical research communications  •  2020  |  View Paper
In SHR/Izm, administration of telmisartan was associated with significantly lower serum levels of free fatty acids (42%), triglycerides (29%), glucose (11%), insulin (31%), and lower hepatic triglyceride (17%) levels, as well as larger epididymal fat pads (1.19-fold) than in SHR/NIH.
Naunyn-Schmiedeberg's Archives of Pharmacology  •  2006  |  View Paper
Interestingly, exposure to high glucose resulted in the increased endothelial permeability of renal glomerular endothelial cells, which was mitigated by treatment with Telmisartan.
Chemical research in toxicology  •  2021  |  View Paper
The results provide evidence that Telmisartan may improve glucose and lipid metabolism with the reduction in visceral fat mass in patients with type 2 diabetes and metabolic syndrome.:
Obesity research & clinical practice  •  2010  |  View Paper